Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 21, 2011 - Issue 10
Submit an article Journal homepage
456
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Inhaled muscarinic antagonists for respiratory diseases: a review of patents and current developments (2006 – 2010)

Maria Prat Almirall R&D Centre, Department of Medicinal Chemistry, Treball 2-4, 08960 Sant Just Desvern, Barcelona, Spain+34 93 2913816; +34 93 3128635; [email protected]
,
Amadeu Gavaldà Almirall R&D Centre, Department of Integrative Pharmacology, Laureà Miró 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
,
Silvia Fonquerna Almirall R&D Centre, Department of Medicinal Chemistry, Treball 2-4, 08960 Sant Just Desvern, Barcelona, Spain+34 93 2913816; +34 93 3128635; [email protected]
&
Montserrat Miralpeix Almirall R&D Centre, Respiratory Therapeutic Area – Discovery, Laureà Miró 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
Pages 1543-1573 | Published online: 25 Jun 2011

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Paul Glossop, Gavin Whitlock & Karl Gibson. (2015) Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 – 2014). Expert Opinion on Therapeutic Patents 25:7, pages 743-754.
Read now
Sabina A Antoniu. (2012) Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis. Expert Opinion on Investigational Drugs 21:11, pages 1607-1618.
Read now
Peter Norman. (2012) Evaluation of WO-2012085582 and WO-2012085583 two identified MABAs: backups to AZD-2115?. Expert Opinion on Therapeutic Patents 22:11, pages 1377-1383.
Read now

Articles from other publishers (2)

Zuojuan Xiang, Jun Liu, Hongbin Sun & Xiaoan Wen. (2017) Discovery of Novel Potent Muscarinic M 3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M 3 Antagonists . ChemMedChem 12:15, pages 1173-1182.
Crossref
Ken-Ichiro Tanaka, Shota Kurotsu, Teita Asano, Naoki Yamakawa, Daisuke Kobayashi, Yasunobu Yamashita, Hiroshi Yamazaki, Tomoaki Ishihara, Hiroshi Watanabe, Toru Maruyama, Hidekazu Suzuki & Tohru Mizushima. (2014) Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease. Scientific Reports 4:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.